|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 8 of 12 found articles
| Title: |
Obinutuzumab pretreatment abrogates tumor lysis risk while maintaining undetectable MRD for venetoclax + obinutuzumab in CLL |
| Author: |
Kater, Arnon P. Kersting, Sabina van Norden, Yvette Dubois, Julie Dobber, Johan A. Mellink, Clemens H. Evers, Ludo M. Croon-de Boer, Fransien Schreurs, John van der Spek, Ellen Visser, Hein Idink, Cecile Wittebol, Shulamiet Hoogendoorn, Mels Tonino, Sanne H. Mobasher, Mehrdad Levin, Mark-David |
| Appeared in: |
Blood advances |
| Paging: | Volume 2 () nr. 24 pages 3566-3571 |
| Year: |
2018 |
| Contents: | |
| Publisher: |
American Society of Hematology |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 8 of 12 found articles
| << previous | next >> |